Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NASH Drug Development: Seeing the Light at the End of the Tunnel? | J Clin Transl Hepatol | 2023 | 37719961 | PubTator, text mining | PubMed |
| Complex effects of sequence variants on lipid levels and coronary artery disease. | Cell | 2023 | 37714134 | PubTator, text mining | PubMed |
| Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD. | Front Endocrinol (Lausanne) | 2023 | 37711901 | PubTator, text mining | PubMed |
| Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. | Nat Genet | 2023 | 37709864 | PubTator, text mining | PubMed |
| Aspirin is associated with a reduced incidence of liver disease in men. | Hepatol Commun | 2023 | 37708453 | PubTator, text mining | PubMed |
| Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 37686134 | PubTator, text mining | PubMed |
| Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adults. | Lipids Health Dis | 2023 | 37679750 | PubTator, text mining | PubMed |
| Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review. | J Int Med Res | 2023 | 37676968 | PubTator, text mining | PubMed |
| Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2. | JHEP Rep | 2023 | 37675273 | PubTator, text mining | PubMed |
| Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease. | Lipids Health Dis | 2023 | 37674196 | PubTator, text mining | PubMed |
| Waiting for the changes after the adoption of steatotic liver disease. | Clin Mol Hepatol | 2023 | 37670441 | PubTator, text mining | PubMed |
| Mitochondrial dynamics in health and disease: mechanisms and potential targets. | Signal Transduct Target Ther | 2023 | 37669960 | PubTator, text mining | PubMed |
| Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions. | Cureus | 2023 | 37664266 | PubTator, text mining | PubMed |
| High-density lipoproteins and non-alcoholic fatty liver disease. | Atheroscler Plus | 2023 | 37663008 | PubTator, text mining | PubMed |
| Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review. | Viruses | 2023 | 37632072 | PubTator, text mining | PubMed |
| Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis. | Viruses | 2023 | 37632067 | PubTator, text mining | PubMed |
| Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD. | Int J Mol Sci | 2023 | 37628929 | PubTator, text mining | PubMed |
| Liver Involvement in Patients with Rare MBOAT7 Variants and Intellectual Disability: A Case Report and Literature Review. | Genes (Basel) | 2023 | 37628684 | PubTator, text mining | PubMed |
Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. | Cancers (Basel) | 2023 | 37627125 | PubTator, text mining | PubMed |
| New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History. | Biomedicines | 2023 | 37626629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=15